Section He-M 1201.11 - Medication Committee(a) The bureau administrator shall appoint a medication committee to review information summarized and submitted on forms required by (g) below.(b) The committee shall be composed of at least the following: (1) The medical director of the bureau or physician designee who shall serve as chairperson of the committee;(2) Two registered nurses from provider agencies;(3) Two non-nurse representatives from provider agencies; and(4) A representative of the bureau.(c) Each provider agency shall complete and submit to the area agency Form 1201-A "Six Month Nurse Trainer Report to NH Bureau of Developmental Services Medication Committee - For Programs with Reportable Errors" (May 2020), or Form 1201-A Short "Programs Without Reportable Errors - Six Month Nurse Trainer Report to NH Bureau of Developmental Services Medication Committee" (May 2020) and Form 1201B "Six Month Provider Agency Report to NH Bureau of Developmental Services Medication Committee" (May 2020) according to Table 12.1.1 for each service in which authorized providers administer medications.(d) Using Form 1201-C "Six Month Area Agency Report to NH Bureau of Developmental Services Medication Committee" (May 2020), an area agency shall report on each provider agency's performance regarding medication administration based on the information submitted through Form 1201-A and Form 1201B.(e) Area agencies shall submit reports prepared on Forms 1201-A, 1201-B, and 1201-C to the bureau.(f) Area agencies and provider agencies shall submit reports in accordance with Table 12.1.1 below: Table 12.1.1
Submission of Six Month Reports to the NH Bureau of Developmental Services
Regions: | Report Period: | Provider Agency Report Due: | Area Agency Report Due: |
1 and 2 | July 1 - December 31 | January 15 | January 31 |
1 and 2 | January 1 - June 30 | July 15 | July 31 |
| | | |
3 and 4 | August 1 - January 31 | February 15 | February 28 |
3 and 4 | February 1 - July 31 | August 15 | August 31 |
| | | |
5 and 6 | September 1 - February 28 | March 15 | March 31 |
5 and 6 | March 1 - August 31 | September 15 | September 30 |
| | | |
7 and 8 | October 1 - March 31 | April 15 | April 30 |
7 and 8 | April 1 - September 30 | October 15 | October 31 |
| | | |
9 and 10 | November 1 - April 30 | May 15 | May 31 |
9 and 10 | May 1 - October 31 | November 15 | November 30 |
(g) The medication committee shall evaluate reports submitted pursuant to (f) above.(h) Upon evaluation of reports submitted pursuant to (f) above, the medication committee shall: (1) Recommend that the bureau administrator accept the report if, as demonstrated by the reports, the area agency or provider agency has complied with the provisions of He-M 1201;(2) Request that additional information be submitted by the area agency; and(3) Identify areas of non-compliance, as demonstrated by the reports, for those area agencies or provider agencies that failed to comply with the provisions of He-M 1201, and make recommendations: a. To the area agency regarding plans for monitoring, oversight, and quality improvement; and b. To the bureau administrator for corrective actions to be taken by those area agencies or provider agencies identified.(i) The bureau administrator shall: (1) Review all recommendations for corrective action made pursuant to (j)(3) above;(2) Require the area agency or provider agency to take corrective action if he or she determines that the action is necessary for the area agency or provider agency to be in compliance with the provisions of He-M 1201; and(3) Send written notification of the required corrective actions in (2) above to the area agency or provider agency.(j) Within 30 days of the date of the written notification in (h)(3) above, the area agency or provider agency shall forward the corrective action plan to the medication committee and fully implement the plan.N.H. Admin. Code § He-M 1201.11
(See Revision Note at part heading for He-M 1201) #4809, eff 5-1-90; ss by #6000, eff 3-21-95; ss by #7836, INTERIM, eff 3-22-03, EXPIRES: 9-18-03; ss by #7956, eff 9-19-03; ss by #9982, eff 9-19-11 (from He-M 1201.10 )
Amended by Volume XXXIX, Number 41, Filed October 10, 2019, Proposed by #12876, Effective 9/25/2019, Expires 3/23/2020.Amended by Volume XL Number 28, Filed July 9, 2020, Proposed by #13057, Effective 6/17/2020, Expires 6/17/2030